These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 34299027)

  • 21. Soluble fms-like tyrosine kinase-1 in HIV infected pre-eclamptic South African Black women.
    Govender N; Moodley J; Gathiram P; Naicker T
    Placenta; 2014 Aug; 35(8):618-24. PubMed ID: 24880209
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis.
    Palmer KR; Tong S; Kaitu'u-Lino TJ
    Mol Hum Reprod; 2017 Feb; 23(2):69-78. PubMed ID: 27986932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dysregulation of the placental renin-angiotensin system in human fetal growth restriction.
    Delforce SJ; Lumbers ER; Ellery SJ; Murthi P; Pringle KG
    Reproduction; 2019 Sep; 158(3):237-245. PubMed ID: 31247590
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion.
    Hastie R; Brownfoot FC; Pritchard N; Hannan NJ; Cannon P; Nguyen V; Palmer K; Beard S; Tong S; Kaitu'u-Lino TJ
    Hypertension; 2019 Mar; 73(3):659-670. PubMed ID: 30636550
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Placental inflammation in pre-eclampsia by Nod-like receptor protein (NLRP)3 inflammasome activation in trophoblasts.
    Stødle GS; Silva GB; Tangerås LH; Gierman LM; Nervik I; Dahlberg UE; Sun C; Aune MH; Thomsen LCV; Bjørge L; Iversen AC
    Clin Exp Immunol; 2018 Jul; 193(1):84-94. PubMed ID: 29683202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidative stress-induced Gadd45α inhibits trophoblast invasion and increases sFlt1/sEng secretions via p38 MAPK involving in the pathology of pre-eclampsia.
    Liu X; Deng Q; Luo X; Chen Y; Shan N; Qi H
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3776-85. PubMed ID: 26809169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effects of gestational age and maternal hypoxia on the placental renin angiotensin system in the mouse.
    Cuffe JS; Walton SL; Steane SE; Singh RR; Simmons DG; Moritz KM
    Placenta; 2014 Nov; 35(11):953-61. PubMed ID: 25249154
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preeclampsia is associated with the presence of transcriptionally active placental fragments in the maternal lung.
    Buurma AJ; Penning ME; Prins F; Schutte JM; Bruijn JA; Wilhelmus S; Rajakumar A; Bloemenkamp KW; Karumanchi SA; Baelde HJ
    Hypertension; 2013 Sep; 62(3):608-13. PubMed ID: 23817495
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating angiogenic factors determined by electrochemiluminescence immunoassay in relation to the clinical features and laboratory parameters in women with pre-eclampsia.
    Molvarec A; Szarka A; Walentin S; Szucs E; Nagy B; Rigó J
    Hypertens Res; 2010 Sep; 33(9):892-8. PubMed ID: 20535121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placental (pro)renin receptor expression and plasma soluble (pro)renin receptor levels in preeclampsia.
    Narita T; Ichihara A; Matsuoka K; Takai Y; Bokuda K; Morimoto S; Itoh H; Seki H
    Placenta; 2016 Jan; 37():72-8. PubMed ID: 26684753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placental expression of adenosine A(2A) receptor and hypoxia inducible factor-1 alpha in early pregnancy, term and pre-eclamptic pregnancies: interactions with placental renin-angiotensin system.
    Kurlak LO; Williams PJ; Bulmer JN; Broughton Pipkin F; Mistry HD
    Placenta; 2015 May; 36(5):611-3. PubMed ID: 25745823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report.
    Ye F; Wang Y; Wu C; Howatt DA; Wu CH; Balakrishnan A; Mullick AE; Graham MJ; Danser AHJ; Wang J; Daugherty A; Lu HS
    Arterioscler Thromb Vasc Biol; 2019 Feb; 39(2):150-155. PubMed ID: 30567480
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of placenta growth factor, soluble fms-like tyrosine kinase-1, metal-responsive transcription factor-1, heme oxygenase 1 and hypoxia inducible factor-1α mRNAs in pre-eclampsia placenta and the effect of pre-eclampsia sera on their expression of choriocarcinoma cells.
    Maebayashi Asanuma A; Yamamoto T; Azuma H; Kato E; Yamamoto N; Murase T; Chishima F; Suzuki M
    J Obstet Gynaecol Res; 2014 Oct; 40(10):2095-103. PubMed ID: 25132343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.
    Gangooly S; Muttukrishna S; Jauniaux E
    PLoS One; 2014; 9(9):e107644. PubMed ID: 25251016
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Placental DAAM2 is unaltered in preeclampsia, but upregulated by treatment with proton pump inhibitors.
    de Alwis N; Beard S; Binder NK; Pritchard N; Tong S; Kaitu'u-Lino TJ; Hannan NJ
    Pregnancy Hypertens; 2022 Dec; 30():13-20. PubMed ID: 35933758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin II induces soluble fms-Like tyrosine kinase-1 release via calcineurin signaling pathway in pregnancy.
    Zhou CC; Ahmad S; Mi T; Xia L; Abbasi S; Hewett PW; Sun C; Ahmed A; Kellems RE; Xia Y
    Circ Res; 2007 Jan; 100(1):88-95. PubMed ID: 17158338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta.
    Jena MK; Sharma NR; Petitt M; Maulik D; Nayak NR
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32599856
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion from human umbilical vein endothelial cells, primary trophoblast cells and placenta.
    Brownfoot FC; Tong S; Hannan NJ; Hastie R; Cannon P; Kaitu'u-Lino TJ
    BMC Pregnancy Childbirth; 2016 May; 16():117. PubMed ID: 27207105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activating Transcription Factor 3 Is Reduced in Preeclamptic Placentas and Negatively Regulates sFlt-1 (Soluble fms-Like Tyrosine Kinase 1), Soluble Endoglin, and Proinflammatory Cytokines in Placenta.
    Kaitu'u-Lino TJ; Brownfoot FC; Hastie R; Chand A; Cannon P; Deo M; Tuohey L; Whitehead C; Hannan NJ; Tong S
    Hypertension; 2017 Nov; 70(5):1014-1024. PubMed ID: 28947613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combining metformin and sulfasalazine additively reduces the secretion of antiangiogenic factors from the placenta: Implications for the treatment of preeclampsia.
    Brownfoot FC; Hastie R; Hannan NJ; Cannon P; Nguyen TV; Tuohey L; Cluver C; Tong S; Kaitu'u-Lino TJ
    Placenta; 2020 Jun; 95():78-83. PubMed ID: 32452405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.